Capital Asset Pricing Model (CAPM)
Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like Biogen Inc. common stock.
Paying user area
Try for free
Biogen Inc. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Price to FCFE (P/FCFE)
- Selected Financial Data since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Price to Book Value (P/BV) since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Biogen Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
Biogen Inc., monthly rates of return
| Biogen Inc. (BIIB) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceBIIB,t1 | DividendBIIB,t1 | RBIIB,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2017 | ||||||
| 1. | Feb 28, 2017 | |||||
| 2. | Mar 31, 2017 | |||||
| 3. | Apr 30, 2017 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2021 | |||||
| 59. | Dec 31, 2021 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
| Biogen Inc. (BIIB) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceBIIB,t1 | DividendBIIB,t1 | RBIIB,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2017 | ||||||
| 1. | Feb 28, 2017 | |||||
| 2. | Mar 31, 2017 | |||||
| 3. | Apr 30, 2017 | |||||
| 4. | May 31, 2017 | |||||
| 5. | Jun 30, 2017 | |||||
| 6. | Jul 31, 2017 | |||||
| 7. | Aug 31, 2017 | |||||
| 8. | Sep 30, 2017 | |||||
| 9. | Oct 31, 2017 | |||||
| 10. | Nov 30, 2017 | |||||
| 11. | Dec 31, 2017 | |||||
| 12. | Jan 31, 2018 | |||||
| 13. | Feb 28, 2018 | |||||
| 14. | Mar 31, 2018 | |||||
| 15. | Apr 30, 2018 | |||||
| 16. | May 31, 2018 | |||||
| 17. | Jun 30, 2018 | |||||
| 18. | Jul 31, 2018 | |||||
| 19. | Aug 31, 2018 | |||||
| 20. | Sep 30, 2018 | |||||
| 21. | Oct 31, 2018 | |||||
| 22. | Nov 30, 2018 | |||||
| 23. | Dec 31, 2018 | |||||
| 24. | Jan 31, 2019 | |||||
| 25. | Feb 28, 2019 | |||||
| 26. | Mar 31, 2019 | |||||
| 27. | Apr 30, 2019 | |||||
| 28. | May 31, 2019 | |||||
| 29. | Jun 30, 2019 | |||||
| 30. | Jul 31, 2019 | |||||
| 31. | Aug 31, 2019 | |||||
| 32. | Sep 30, 2019 | |||||
| 33. | Oct 31, 2019 | |||||
| 34. | Nov 30, 2019 | |||||
| 35. | Dec 31, 2019 | |||||
| 36. | Jan 31, 2020 | |||||
| 37. | Feb 29, 2020 | |||||
| 38. | Mar 31, 2020 | |||||
| 39. | Apr 30, 2020 | |||||
| 40. | May 31, 2020 | |||||
| 41. | Jun 30, 2020 | |||||
| 42. | Jul 31, 2020 | |||||
| 43. | Aug 31, 2020 | |||||
| 44. | Sep 30, 2020 | |||||
| 45. | Oct 31, 2020 | |||||
| 46. | Nov 30, 2020 | |||||
| 47. | Dec 31, 2020 | |||||
| 48. | Jan 31, 2021 | |||||
| 49. | Feb 28, 2021 | |||||
| 50. | Mar 31, 2021 | |||||
| 51. | Apr 30, 2021 | |||||
| 52. | May 31, 2021 | |||||
| 53. | Jun 30, 2021 | |||||
| 54. | Jul 31, 2021 | |||||
| 55. | Aug 31, 2021 | |||||
| 56. | Sep 30, 2021 | |||||
| 57. | Oct 31, 2021 | |||||
| 58. | Nov 30, 2021 | |||||
| 59. | Dec 31, 2021 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of BIIB during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
Biogen Inc., calculation of variance and covariance of returns
| t | Date | RBIIB,t | RS&P 500,t | (RBIIB,t–RBIIB)2 | (RS&P 500,t–RS&P 500)2 | (RBIIB,t–RBIIB)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2017 | |||||
| 2. | Mar 31, 2017 | |||||
| 3. | Apr 30, 2017 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2021 | |||||
| 59. | Dec 31, 2021 | |||||
| Total (Σ): | ||||||
| t | Date | RBIIB,t | RS&P 500,t | (RBIIB,t–RBIIB)2 | (RS&P 500,t–RS&P 500)2 | (RBIIB,t–RBIIB)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2017 | |||||
| 2. | Mar 31, 2017 | |||||
| 3. | Apr 30, 2017 | |||||
| 4. | May 31, 2017 | |||||
| 5. | Jun 30, 2017 | |||||
| 6. | Jul 31, 2017 | |||||
| 7. | Aug 31, 2017 | |||||
| 8. | Sep 30, 2017 | |||||
| 9. | Oct 31, 2017 | |||||
| 10. | Nov 30, 2017 | |||||
| 11. | Dec 31, 2017 | |||||
| 12. | Jan 31, 2018 | |||||
| 13. | Feb 28, 2018 | |||||
| 14. | Mar 31, 2018 | |||||
| 15. | Apr 30, 2018 | |||||
| 16. | May 31, 2018 | |||||
| 17. | Jun 30, 2018 | |||||
| 18. | Jul 31, 2018 | |||||
| 19. | Aug 31, 2018 | |||||
| 20. | Sep 30, 2018 | |||||
| 21. | Oct 31, 2018 | |||||
| 22. | Nov 30, 2018 | |||||
| 23. | Dec 31, 2018 | |||||
| 24. | Jan 31, 2019 | |||||
| 25. | Feb 28, 2019 | |||||
| 26. | Mar 31, 2019 | |||||
| 27. | Apr 30, 2019 | |||||
| 28. | May 31, 2019 | |||||
| 29. | Jun 30, 2019 | |||||
| 30. | Jul 31, 2019 | |||||
| 31. | Aug 31, 2019 | |||||
| 32. | Sep 30, 2019 | |||||
| 33. | Oct 31, 2019 | |||||
| 34. | Nov 30, 2019 | |||||
| 35. | Dec 31, 2019 | |||||
| 36. | Jan 31, 2020 | |||||
| 37. | Feb 29, 2020 | |||||
| 38. | Mar 31, 2020 | |||||
| 39. | Apr 30, 2020 | |||||
| 40. | May 31, 2020 | |||||
| 41. | Jun 30, 2020 | |||||
| 42. | Jul 31, 2020 | |||||
| 43. | Aug 31, 2020 | |||||
| 44. | Sep 30, 2020 | |||||
| 45. | Oct 31, 2020 | |||||
| 46. | Nov 30, 2020 | |||||
| 47. | Dec 31, 2020 | |||||
| 48. | Jan 31, 2021 | |||||
| 49. | Feb 28, 2021 | |||||
| 50. | Mar 31, 2021 | |||||
| 51. | Apr 30, 2021 | |||||
| 52. | May 31, 2021 | |||||
| 53. | Jun 30, 2021 | |||||
| 54. | Jul 31, 2021 | |||||
| 55. | Aug 31, 2021 | |||||
| 56. | Sep 30, 2021 | |||||
| 57. | Oct 31, 2021 | |||||
| 58. | Nov 30, 2021 | |||||
| 59. | Dec 31, 2021 | |||||
| Total (Σ): | ||||||
Show all
VarianceBIIB = Σ(RBIIB,t–RBIIB)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceBIIB, S&P 500 = Σ(RBIIB,t–RBIIB)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
| VarianceBIIB | |
| VarianceS&P 500 | |
| CovarianceBIIB, S&P 500 | |
| Correlation coefficientBIIB, S&P 5001 | |
| βBIIB2 | |
| αBIIB3 |
Calculations
1 Correlation coefficientBIIB, S&P 500
= CovarianceBIIB, S&P 500 ÷ (Standard deviationBIIB × Standard deviationS&P 500)
= ÷ ( × )
=
2 βBIIB
= CovarianceBIIB, S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αBIIB
= AverageBIIB – βBIIB × AverageS&P 500
= – ×
=
Expected Rate of Return
| Assumptions | ||
| Rate of return on LT Treasury Composite1 | RF | |
| Expected rate of return on market portfolio2 | E(RM) | |
| Systematic risk (β) of Biogen Inc. common stock | βBIIB | |
| Expected rate of return on Biogen Inc. common stock3 | E(RBIIB) | |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RBIIB) = RF + βBIIB [E(RM) – RF]
= + [ – ]
=